News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Alan Marcus

Advertisement

Articles by Alan Marcus

Policastro and Marcus

Changing the Paradigm in AI Implementation

ByAlan Marcus,Jeff Policastro
November 13th 2023

How pharma companies can reduce the risk of failure with AI-based innovations.

Inside the Lab of the Future: How Advanced Technologies and Optimized Lab Informatics Can Turn Scientific Data into a Valuable Business Asset

ByAlan Marcus
August 16th 2023
Advertisement

Latest Updated Articles

  • Policastro and Marcus
    Changing the Paradigm in AI Implementation

    Published: November 13th 2023 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Brent Saunders: Eyeing New Horizons

2

TrumpRX Has a Blind Spot and It Can Redefine Patient Access

3

Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial

4

FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies

5

The GLP-1 Gold Rush

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us